Despite the challenging macro backdrop, OTC consumer healthcare firm Venture Life (VLG ) is performing well. Find out here from CEO Jerry Randall what’s driving the growth & improving profit margins, including:
H1 financial highlights & margin improvement. 01:35
3rd party products. 03:45
Balance sheet protection, if orders were ever cancelled. 05:35
Clarification of ‘Legacy’ business? 06:50
Chinese partnership. 07:45
Orderbook growth & positive H2 outlook. 09:35
Underlying cash generation. 12:25
Disciplined M&A strategy. 13:45
Operating leverage & spare manufacturing capacity. 15:30
Ultimate profit margin target. 17:05
Is there a DTC opportunity too. 18:20
Future newsflow. 19:25
Q&A with Venture Life, CEO Jerry Randall
Sep 23, 2022Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.